Internal Medicine, Hospice and Palliative Medicine · Daytona Beach, FL
NPI
1881754281
Since 2006
Specialty
Internal Medicine, Hospice and Palliative Medicine
Code 207RH0002X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
303 N Clyde Morris Blvd
Daytona Beach, FL, 32114
Phone (386) 425-6321
Groups this clinician bills Medicare through
Medicare paid, 2024
$181K
2,001 services
Medicare patients, 2024
808
Average age 83
Drug cost, 2024
$4.3M
57,299 prescriptions
Company payments, 2025
$377
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shahzad Khurshid was code 99308 (snf e&m), 626 times for 317 patients. In total Shahzad Khurshid billed 2,001 services in 17 codes, and Medicare paid $181K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 626 | 317 | $58.40 | $37K |
| 99309 SNF E&M | Facility | 510 | 314 | $84.89 | $43K |
| 99305 SNF E&M | Facility | 384 | 332 | $105.31 | $40K |
| 99306 SNF E&M | Facility | 365 | 317 | $143.79 | $52K |
| G0182 Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patien | Office | 20 | 18 | $83.49 | $1,670 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 15 | 14 | $43.16 | $647 |
By year: 2022 $152K for 1,850 services; 2023 $196K for 2,221 services; 2024 $181K for 2,001 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shahzad Khurshid prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,914 prescriptions and refills. In total Shahzad Khurshid wrote 57,299 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,914 | 3,033 | 534 | $54K |
| Eliquis Apixaban | 2,655 | 2,655 | 254 | $762K |
| Furosemide Generic | 2,160 | 2,190 | 311 | $15K |
| Levothyroxine Sodium Generic | 2,134 | 2,162 | 254 | $25K |
| Trazodone Hcl Generic | 1,963 | 1,987 | 357 | $29K |
| Gabapentin Generic | 1,734 | 1,792 | 272 | $35K |
| Amlodipine Besylate Generic | 1,627 | 1,771 | 286 | $21K |
| Mirtazapine Generic | 1,501 | 1,511 | 249 | $41K |
| Sertraline Hcl Generic | 1,501 | 1,507 | 210 | $29K |
| Lisinopril Generic | 1,347 | 1,395 | 207 | $18K |
| Metoprolol Tartrate Generic | 1,247 | 1,263 | 193 | $15K |
| Quetiapine Fumarate Generic | 1,120 | 1,120 | 122 | $20K |
| Pantoprazole Sodium Generic | 1,101 | 1,117 | 211 | $25K |
| Metformin Hcl Generic | 951 | 1,005 | 151 | $20K |
| Tamsulosin Hcl Generic | 910 | 926 | 161 | $21K |
Brand drugs: 11,424 claims; generic drugs: 45,671 claims; opioid claims: 487.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shahzad Khurshid $377 ($377 in general payments such as food, travel and fees) from 10 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $61.02.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $61.02 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $55.04 |
| Exact Sciences Corporation EXAS | 2 | $47.69 |
| Lundbeck LLC | 2 | $47.21 |
| Abbvie Inc. ABBV | 2 | $43.41 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $40.1 |
| Neurelis, Inc. | 1 | $22.64 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $21.73 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $19.84 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $17.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.